A Armuzzi

Summary

Publications

  1. ncbi request reprint High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility
    T Ahmad
    Gastroenterology Unit, University of Oxford, Gibson Laboratories, Radcliffe Infirmary, UK
    Tissue Antigens 60:164-79. 2002
  2. ncbi request reprint Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn's disease
    L Guidi
    Dipartimento di Medicina Interna, Scienze Specialistiche e Dermatologia, Catholic University, Rome, Italy
    Eur Rev Med Pharmacol Sci 10:23-6. 2006
  3. doi request reprint Infliximab in Crohn's disease: early and long-term treatment
    A Armuzzi
    Internal Medicine Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy
    Dig Liver Dis 40:S271-9. 2008
  4. ncbi request reprint Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study
    Alessandro Armuzzi
    IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy Electronic address
    J Crohns Colitis 7:e623-9. 2013
  5. ncbi request reprint Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis
    G Andrisani
    Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy
    Reumatismo 65:75-8. 2013
  6. pmc Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab
    Alessandro Armuzzi
    IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy
    Drug Des Devel Ther 7:289-96. 2013
  7. doi request reprint Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission
    Alessandro Armuzzi
    Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy
    Inflamm Bowel Dis 19:1065-72. 2013
  8. ncbi request reprint IBD: Adalimumab for ulcerative colitis— is the glass half empty or half full?
    Alessandro Armuzzi
    Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Via Moscati 31, Rome, Italy
    Nat Rev Gastroenterol Hepatol 8:249-51. 2011
  9. pmc Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31
    A Armuzzi
    Gastroenterology Unit, University of Oxford, Gibson Laboratories, Radcliffe Infirmary, Oxford, UK
    Gut 52:1133-9. 2003
  10. ncbi request reprint Association between Helicobacter pylori cytotoxic type I CagA-positive strains and migraine with aura
    A Gasbarrini
    Angiology Department, Catholic University, Rome, Italy
    Cephalalgia 20:561-5. 2000

Collaborators

Detail Information

Publications43

  1. ncbi request reprint High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility
    T Ahmad
    Gastroenterology Unit, University of Oxford, Gibson Laboratories, Radcliffe Infirmary, UK
    Tissue Antigens 60:164-79. 2002
    ..Linkage disequilibrium patterns between HLA-B, MICA and MICB are presented. Analysis by individual allele or by multilocus haplotype failed to identify any significant disease associations...
  2. ncbi request reprint Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn's disease
    L Guidi
    Dipartimento di Medicina Interna, Scienze Specialistiche e Dermatologia, Catholic University, Rome, Italy
    Eur Rev Med Pharmacol Sci 10:23-6. 2006
    ..v. SonoVue during infliximab therapy might represent an useful, not invasive and relatively low cost imaging modality for the clinical monitoring of activity of small bowel Crohn's disease...
  3. doi request reprint Infliximab in Crohn's disease: early and long-term treatment
    A Armuzzi
    Internal Medicine Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy
    Dig Liver Dis 40:S271-9. 2008
    ....
  4. ncbi request reprint Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study
    Alessandro Armuzzi
    IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy Electronic address
    J Crohns Colitis 7:e623-9. 2013
    ....
  5. ncbi request reprint Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis
    G Andrisani
    Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy
    Reumatismo 65:75-8. 2013
    ..Moreover, Adalimumab is a well-established treatment for RA. Herein, we describe a patient with RA and UC treated successfully with ADA. ..
  6. pmc Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab
    Alessandro Armuzzi
    IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy
    Drug Des Devel Ther 7:289-96. 2013
    ..Taken together, the current evidence indicates that adalimumab is effective for the treatment of patients with different types of ulcerative colitis, including biologically naïve and difficult-to-treat patients...
  7. doi request reprint Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission
    Alessandro Armuzzi
    Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy
    Inflamm Bowel Dis 19:1065-72. 2013
    ..Aims of this study were to evaluate the effectiveness of infliximab in steroid-dependent UC and identify predictors of steroid-free remission, mucosal healing (MH), and colectomy...
  8. ncbi request reprint IBD: Adalimumab for ulcerative colitis— is the glass half empty or half full?
    Alessandro Armuzzi
    Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Via Moscati 31, Rome, Italy
    Nat Rev Gastroenterol Hepatol 8:249-51. 2011
    ..The results of a randomized controlled trial of adalimumab for inducing remission in moderately to severely active ulcerative colitis have now been published...
  9. pmc Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31
    A Armuzzi
    Gastroenterology Unit, University of Oxford, Gibson Laboratories, Radcliffe Infirmary, Oxford, UK
    Gut 52:1133-9. 2003
    ..No data regarding the contribution of this locus to clinical phenotype exist. In this case control study, we investigated the contribution of this haplotype to both susceptibility and phenotype of CD and UC...
  10. ncbi request reprint Association between Helicobacter pylori cytotoxic type I CagA-positive strains and migraine with aura
    A Gasbarrini
    Angiology Department, Catholic University, Rome, Italy
    Cephalalgia 20:561-5. 2000
    ..A higher inflammatory response of the gastric mucosa to more virulent strains could release substances that may act as triggers of vasospasm in peculiar cerebral arterial districts, probably implicated in the 'aura' phenomenon...
  11. ncbi request reprint 13C-methionine breath tests for mitochondrial liver function assessment
    M Candelli
    Internal Medicine Department, Catholic University of Sacred Heart, Rome, Italy
    Eur Rev Med Pharmacol Sci 12:245-9. 2008
    ....
  12. ncbi request reprint The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy
    A Armuzzi
    Department of Internal Medicine, Catholic University, Rome, Italy
    Aliment Pharmacol Ther 15:163-9. 2001
    ..04). CONCLUSIONS: Lactobacillus GG supplementation showed a positive impact on H. pylori therapy-related side-effects and on overall treatment tolerability...
  13. ncbi request reprint The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis
    T Ahmad
    Gastroenterology Unit, University of Oxford, Gibson Laboratories, Radcliffe Infirmary, Woodstock Road, Oxford, UK
    Tissue Antigens 62:527-35. 2003
    ..Genes in the HLA play a role in modifying disease phenotype. Further studies are required to dissect how these genes functionally interact with each other and with environmental factors to determine clinical patterns of disease..
  14. pmc Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants
    G Andrisani
    Operative Unit of Internal Medicine and Gastroenterology, Complesso Integrato Columbus, Catholic University Sacro Cuore, Roma, Italy
    J Crohns Colitis 7:301-7. 2013
    ..Second and third aims were the safety of pH1N1 vaccine and the effects on IBD clinical activity...
  15. ncbi request reprint 13C-breath tests in the study of microsomal liver function
    E C Nista
    Internal Medicine Dept, Catholic University Agostino Gemelli Hospital, Rome, Italy
    Eur Rev Med Pharmacol Sci 8:33-46. 2004
    ..The aim of this review is to describe the clinical applications of microsomal liver breath tests in different hepatic diseases...
  16. ncbi request reprint Efficacy and tolerability of antibiotics in patients undergoing H. pylori eradication
    S Danese
    Internal Medicine Department, Gemelli Hospital, Catholic University, Rome, Italy
    Hepatogastroenterology 48:465-7. 2001
    ..Quadruple therapy, which appear highly efficacious as a second line therapy, is associated with a significantly higher incidence of side effects when compared to first-line treatment...
  17. ncbi request reprint Prevalence of and risk factors for Helicobacter pylori infection among healthcare workers at a teaching hospital in Rome: the Catholic University Epidemiological Study
    A Gasbarrini
    Department of Medical Pathology, Gemelli Hospital, Catholic University, Rome, Italy
    Eur J Gastroenterol Hepatol 13:185-9. 2001
    ..To evaluate the prevalence of and the risk factors for Helicobacter pylori in a population of medical and non-medical workers at a teaching hospital in Rome, Italy...
  18. ncbi request reprint 13C-breath tests in the study of mitochondrial liver function
    M Candelli
    Internal Medicine Dept, Catholic University Agostino Gemelli Hospital, Rome, Italy
    Eur Rev Med Pharmacol Sci 8:23-31. 2004
    ....
  19. ncbi request reprint New biological agents for the treatment of the "high risk" IBD patients
    L Guidi
    U O C Medicina Interna e Gastroenterologia, Complesso Integrato Columbus, Universita Cattolica del Sacro Cuore, Roma, Italy
    Eur Rev Med Pharmacol Sci 14:342-6. 2010
    ..This association is well known from many years. However, the mechanisms linking chronic inflammation and carcinogenesis are beginning to be elucidated only recently...
  20. ncbi request reprint Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease
    A Papa
    Department of Internal Medicine, Gastroenterology Unit, Catholic University of Rome, A Gemelli University Hospital, Largo A Gemelli 8, 00168 Rome, Italy
    Dig Liver Dis 36:528-32. 2004
    ..Intercellular adhesion molecule 1 gene lies on chromosome 19p13, implicated in determining susceptibility to inflammatory bowel disease. Recently, the polymorphism K469E of intercellular adhesion molecule 1 gene has been identified...
  21. ncbi request reprint Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa
    S Danese
    Dept. of Clinical Chemistry, Gemelli Hospital, Catholic University, Rome, Italy
    Scand J Gastroenterol 36:247-50. 2001
    ..Assessment of CagA status might be useful to discriminate patients in which H. pylori eradication is advisable...
  22. ncbi request reprint Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis
    M A Zocco
    Department of Internal Medicine, Catholic University of Rome, Rome, Italy
    Aliment Pharmacol Ther 23:1567-74. 2006
    ..Aminosalicylates are the mainstay of therapy to prevent relapse of quiescent ulcerative colitis. The rationale for using probiotics is based on the evidence implicating intestinal bacteria in the pathogenesis of this disorder...
  23. ncbi request reprint Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria
    V Ojetti
    Department of Internal Medicine, Catholic University, Rome, Italy
    Int Arch Allergy Immunol 125:66-72. 2001
    ..CONCLUSIONS: Although H. pylori infection affects gastric juice ECP and eosinophil infiltration of ICU patients, the role of the bacterium in the pathogenesis of this skin disorder still remains uncertain...
  24. ncbi request reprint Epithelial cell turnover and apoptosis
    M Anti
    Chair of Internal Medicine, Catholic University, Rome, Italy
    Ital J Gastroenterol Hepatol 30:S276-8. 1998
    ..However, further studies are needed to elucidate this issue in humans...
  25. ncbi request reprint Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease
    F Schinzari
    Division of Terapia Medica, Department of Internal Medicine, Complesso Integrato Columbus, Universita Cattolica del Sacro Cuore, Rome, Italy
    Clin Pharmacol Ther 83:70-6. 2008
    ..These findings underscore the role of selective cytokine targeting in improving endothelial function in patients with Crohn's disease...
  26. ncbi request reprint Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab
    G Andrisani
    IBD Unit, Complesso Integrato Columbus Gemelli Hospital, School of Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Eur Rev Med Pharmacol Sci 17:2831-6. 2013
    ..We report about the effectiveness of ustekinumab in the treatment of both severe scalp psoriasis lesions with alopecia and active Crohn's disease. ..
  27. ncbi request reprint Anti-TNF alpha therapy in the management of extraintestinal manifestation of inflammatory bowel disease
    G Andrisani
    Complesso Integrato Columbus, School of Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Eur Rev Med Pharmacol Sci 16:890-901. 2012
    ....
  28. ncbi request reprint A novel pathogenic role for microvasculature in inflammatory bowel disease
    S Danese
    Department of Internal Medicine, Catholic University of Rome, Rome, Italy
    Eur Rev Med Pharmacol Sci 10:3-5. 2006
    ..Interestingly, endothelium has become one of the major areas of investigation in gut inflammation...
  29. pmc Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas
    M Anti
    Department of Internal Medicine, Catholic University of Rome, Rome, Italy
    Gut 48:238-46. 2001
    ..Alterations in epithelial proliferation and apoptosis in colonic mucosa are associated with an increased risk of colon cancer. It is unclear if these alterations represent a generalised "field defect"...
  30. ncbi request reprint Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
    M Candelli
    Department of Internal Medicine, Catholic University of Sacred Heart, Rome, Italy
    Hepatogastroenterology 50:718-20. 2003
    ..The aim of this study was to assess the sensitivity and specificity of antibodies to Saccharomyces cerevisiae for Crohn's disease in an Italian population and to evaluate their clinical role...
  31. doi request reprint A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery
    G Andrisani
    Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy
    J Crohns Colitis 7:421-6. 2013
    ..The surgical approach to PG is reserved to a few selected cases. We report here the case of a patient with ulcerative colitis (UC) and PG localized on the left breast, treated with a simultaneous combined medical and surgical approach...
  32. ncbi request reprint Growth hormone in inflammatory bowel disease
    B De Pascalis
    Department of Internal Medicine, Catholic University, Rome, Italy
    Eur Rev Med Pharmacol Sci 10:13-6. 2006
    ..Recent in vivo data have shown that acquired growth hormone resistance in patients with inflammatory bowel disease may be reversed after the administration of anti-TNF-alpha therapy...
  33. ncbi request reprint Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up
    A Kohn
    Azienda Ospedaliera San Camillo Forlanini, Rome, Italy
    Aliment Pharmacol Ther 26:747-56. 2007
    ..Severe ulcerative colitis is a life-threatening disorder, despite i.v. glucocorticoids treatment. Infliximab has been proposed as a safe rescue therapy...
  34. ncbi request reprint Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure
    C Di Campli
    Dept of Internal Medicine and Intensive Care Unit, Catholic University of Rome, Rome, Italy
    Curr Med Chem 10:341-8. 2003
    ..Further advances in the MARS components will definitively state whether albumin dialysis may represent the future in the field of artificial liver devices...
  35. ncbi request reprint Review article: breath testing for human liver function assessment
    A Armuzzi
    Department of Internal Medicine, Catholic University, Rome, Italy
    Aliment Pharmacol Ther 16:1977-96. 2002
    ....
  36. ncbi request reprint Probiotics and Helicobacter pylori eradication
    F Canducci
    Internal Medicine Department, Catholic University, Rome, Italy
    Dig Liver Dis 34:S81-3. 2002
    ....
  37. ncbi request reprint NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population
    R W L Leong
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China
    Aliment Pharmacol Ther 17:1465-70. 2003
    ..Whether these SNPs are involved in the pathogenesis of Crohn's disease in the Chinese population is unknown...
  38. pmc Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in different populations
    A Papa
    Gut 52:1227-8; author reply 1228. 2003
  39. ncbi request reprint Sacroileitis and peripheral arthropathy associated with ulcerative colitis: effect of infliximab on both articular and intestinal symptoms
    A Lupascu
    Department of Internal Medicine, Catholic University of Rome, Largo A Gemelli 8, Rome 00168, Italy
    Dig Liver Dis 36:423-5. 2004
    ..Here, we report a case of a patient with sacroileitis and peripheral arthropathy associated with left-sided ulcerative colitis who achieved a sustained clinical remission after infliximab therapy...
  40. ncbi request reprint Infliximab in the treatment of steroid-dependent ulcerative colitis
    A Armuzzi
    Department of Internal Medicine, Gemelli Hospital, Catholic University of Rome Italy
    Eur Rev Med Pharmacol Sci 8:231-3. 2004
    ..Limited and contrasting data are available on effectiveness of anti-TNF alpha therapy in ulcerative colitis. We evaluated the efficacy of infliximab in the management of steroid-dependent ulcerative colitis...
  41. ncbi request reprint Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation
    S Danese
    Department of Internal Medicine, Catholic University School of Medicine, L go Vito 1, 00168 Rome, Italy
    Dig Liver Dis 37:811-8. 2005
    ..This paper reviews the major molecules that mediate leukocyte-endothelial interactions, and summarises the results of the most recent clinical trials targeting adhesion molecules in inflammatory bowel disease...